SCHEMBL467185

SCHEMBL467185

O=C1CCCCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7622223 0.97
SCHEMBL22319277 0.97 TRIM24 (0.50)
SCHEMBL14603032 0.97 TRIM24 (0.50)
SCHEMBL7618081 0.97 TRIM24 (0.50)
SCHEMBL22319259 0.97 TRIM24 (0.50)
SCHEMBL22319263 0.97 TRIM24 (0.50)
SCHEMBL29018325 0.97 TRIM24 (0.50)
Hydrochloric Acid SCHEMBL22469519 0.97
SCHEMBL22319290 0.97 TRIM24 (0.50)
SCHEMBL14790892 0.95 TRIM24 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 363 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117881397-A Heterocyclic compounds and methods of use 安进公司 2024-04-12 CN claimed
US-20160303139-A1 TARGETING PRIMARY CILIA TO TREAT GLAUCOMA UNIV INDIANA RES & TECH CORP (US) 2016-10-20 US claimed
US-20150231148-A1 TARGETING PRIMARY CILIA TO TREAT GLAUCOMA NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-08-20 US claimed
EP-1796677-A4 METHOD FOR ACTIVATING TRPV4 CHANNEL RECEPTORS BY AGONISTS SMITHKLINE BEECHAM CORP (US) 2009-07-08 EP claimed
EP-1796677-A2 METHOD FOR ACTIVATING TRPV4 CHANNEL RECEPTORS BY AGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2007-06-20 EP claimed
WO-2006029209-A2 METHOD FOR ACTIVATING TRPV4 CHANNEL RECEPTORS BY AGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2006-03-16 WO claimed
EP-1436255-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2004-07-14 EP claimed
WO-2003024924-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2003-03-27 WO claimed
EP-0258391-A1 USE OF HETEROCYCLIC NITROGEN-CONTAINING COMPOUNDS FOR REDUCING MOISTURE LOSS FROM PLANTS AND INCREASING CROP YIELD RHONE POULENC NEDERLAND B.V. (NL) 1988-03-09 EP claimed
WO-1987004321-A2 USE OF HETEROCYCLIC NITROGEN-CONTAINING COMPOUNDS FOR REDUCING MOISTURE LOSS FROM PLANTS AND INCREASING CROP YIELD RHONE-POULENC NEDERLANDS B.V. (NL) 1987-07-30 WO claimed
US-12338376-B2 Adhesive, laminated film, and production method for laminated film DIC CORPORATION (JP) 2025-06-24 US disclosed
EP-4472980-A2 QUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2024-12-11 EP disclosed
EP-3966035-B1 ELASTOMERIC CHEMICAL BARRIER ARTICLES ANSELL LTD (AU) 2024-12-04 EP disclosed
US-20240368001-A1 SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2024-11-07 US disclosed
CN-118660880-A Quinazoline pan KRAS inhibitors 米拉蒂治疗股份有限公司 2024-09-17 CN disclosed
US-4058658-A Copolymers of ω-bromoalkyl esters of acyclic unsaturated dicarboxylic acids MONSANTO COMPANY (US) 1977-11-15 US disclosed
US-4046891-A Smooth muscle relaxant process employing 10-imidoylphenoxazines MEAD JOHNSON & COMPANY (US) 1977-09-06 US disclosed
US-3976619-A Flame retardant polymers containing phosphates MONSANTO COMPANY (US) 1976-08-24 US disclosed
US-3968187-A Flame retardant haloalkyl esters of glycols MONSANTO COMPANY (US) 1976-07-06 US disclosed
US-3962252-A 10-IMIDOYLACRIDANS MEAD JOHNSON & COMPANY (US) 1976-06-08 US disclosed